Greenwich LifeSciences, Inc. GLSI

$18.70 +35.90% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-11-16 View →
DEF 14A DEF 14A 2026-10-26 View →
10-Q 10-Q 2026-08-11 View →
4 4 2026-07-30 View →
4 4 2026-07-29 View →
4 4 2026-07-27 View →
10-Q 10-Q 2026-06-04 View →
10-K 10-K 2026-06-01 View →
4 4 2026-01-15 View →
4 4 2026-01-14 View →
4 4 2026-01-05 View →
4 4 2026-01-02 View →
4 4 2025-12-19 View →
8-K 8-K 2025-12-18 View →
4 4 2025-11-28 View →
4 Insider transaction 2025-11-17 View →
10-Q 10-Q 2025-11-14 View →
4 4 2025-11-12 View →
4 Insider transaction 2025-11-04 View →
DEF 14A DEF 14A 2025-11-03 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-07-24 View →
10-Q 10-Q 2025-05-20 View →
4 Insider transaction 2025-04-29 View →
4 Insider transaction 2025-04-22 View →
10-K Annual report 2025-04-15 View →
4 Insider transaction 2025-04-08 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-01-13 View →
4 Insider transaction 2025-01-08 View →
4 Insider transaction 2025-01-07 View →
4 Insider transaction 2025-01-06 View →
4 Insider transaction 2025-01-03 View →
4 Insider transaction 2025-01-02 View →
4 Insider transaction 2024-12-27 View →
4 Insider transaction 2024-12-27 View →
4 Insider transaction 2024-12-27 View →
4 Insider transaction 2024-12-27 View →
4 Insider transaction 2024-12-27 View →
4 Insider transaction 2024-12-27 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$18.70
Market Cap
$201.97 million
52-Week Range
$7.78 – $34.10
Average Volume
169K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.